Three-Statement Breakdown
REVENUE DOWN
Revenue fell 3.5% year over year to $34.2B, and carried a 6.1% net margin.
REVENUE
-3.5%
34,187
GROSS PROFIT
—
—
NET INCOME
-47.2%
2,078
EPS (DILUTED)
-44.2%
$7.98
| Income statement | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | YoY | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
|
20,572 | 22,260 | 22,489 | 27,131 | 33,671 | 34,233 | 35,441 | 34,187 | -3.5% |
| Gross profit |
NOT DISCLOSED
|
3,689 | 4,236 | 4,748 | — | — | — | — | — | — |
| SG&A |
NOT DISCLOSED
|
(344) | (321) | (333) | (398) | — | (2,231) | (2,480) | (2,678) | +8.0% |
| Operating income |
NOT DISCLOSED
|
2,463 | 2,775 | 3,482 | — | — | — | — | — | — |
| Income tax |
|
(545) | (592) | (656) | (1,363) | (1,366) | (1,241) | (1,217) | (706) | -42.0% |
| Net income |
|
1,696 | 1,849 | 2,465 | 4,430 | 4,614 | 3,939 | 3,933 | 2,078 | -47.2% |
| EPS (diluted) |
|
$5.44 | $5.74 | $7.85 | $14.27 | $15.72 | $13.73 | $14.31 | $7.98 | -44.2% |
Click a line to select it — Enter or the EXPAND pill folds out its quarter-by-quarter history.
No comparable bridge for this view yet.
↹ CLICK A LINE TO SELECT · ⌘F FIND LINE ITEM
SRC 10-Q FILED 2026-06-29 ↗